Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity

Browse by...

Deposit

Highlights

More informations

Title		Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity
Authors		Bouatou, Yassine Samer, Caroline Flora Ing Lorenzini, Kuntheavy Roseline Daali, Youssef Daou, Samira Fathi, Marc Rebsamen, Michela Desmeules, Jules Alexandre Calmy, Alexandra Escher, Monica show all authors [1 - 10]
Published in		AIDS research and therapy. 2014, vol. 11, 25
Abstract		Voriconazole is metabolized by cytochrome P450 (CYP) 2C19 and CYP 3A4. Drug-drug interactions and genetic polymorphisms modulate their activities.
Identifiers		DOI: 10.1186/1742-6405-11-25 PMID: 25120580
Full text		Article (Published version) (263 Kb) - Free access
Structures		Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences Faculté des sciences / Section des sciences pharmaceutiques
Research groups		Groupe Desmeules Jules (pharmacologie/toxicologie) (567) Pharmaco-omiques et médecine de précision (1003) VIH/SIDA (930)
Citation (ISO format)		BOUATOU, Yassine et al. Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity. In: AIDS research and therapy, 2014, vol. 11, p. 25. doi: 10.1186/1742-6405-11-25 https://archive-ouverte.unige.ch/unige:43677